Funding for this research was provided by:
Text and Data Mining valid from 2018-05-31
Received: 13 September 2017
Accepted: 4 May 2018
First Online: 31 May 2018
Ethics approval and consent to participate
: Internal Committee of Biomedical experiments board of Philips Research has approved the study protocol concerning the healthy participants. The Medical Ethics Committee of Maxima Medical Center in Veldhoven and the Internal Committee of Biomedical experiments have approved the study protocol regarding the coronary artery disease patients. All participants provided written informed consent.
: All authors work for Royal Philips Electronics B.V., which may benefit from the results of the present study. Royal Philips Electronics B.V. did not play any role in determining the study design, collection, analysis and interpretation of data. The decision to submit the report for publication was approved by Royal Philips Electronics B.V. upfront. The authors had full access to all of the data in this study and they take complete responsibility for the integrity of the data and the accuracy of the data analysis. The authors declare that the results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.